Hereditary melanoma: Prevalence of risk factors in a group of patients in Southern Brazil;Melanoma hereditário: Prevalência de fatores de risco em um grupo de pacientes no Sul do Brasil

Anais Brasileiros de Dermatologia

Volumn 79, Issue 1, 2004, Pages 53-60

  Carvalho, Charles André ^a   Da Cunha, Mauricio Estrela ^a   Giugliani, Roberto ^a   Bakos, Lucio ^a   Ashton Prolla, Patrícia ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Genes, tumor suppressor; Melanoma; Neoplastic syndromes, hereditary

Indexed keywords

ADULT; ARTICLE; BRAZIL; CANCER MORTALITY; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MORBIDITY; PREVALENCE; RISK FACTOR;

EID: 1542289991     PISSN: 03650596     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0365-05962004000100006     Document Type: Article

References (21)

1. Bressac-de-Paillerets B, Avril MF, Chompret A, Demenais F. Genetic and environmental factors in cutaneous malignant melanoma. Biochimie 2002; 84: 67-74.
2. Melanoma - National Cancer Institute - CancerNet: http://cancernet.nci.nih.gov
3. Melanoma: epidemic or better detection? Harv Health Lett. 2002 Jul;27(9):7.
4. Howe HL, Wingo PA, Thun MJ, et al. Annual report to the Nation on the Status of Cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst. 2001;93:824-842.
5. Instituto Nacional do Câncer, Brasil. http://www.inca.org.br
6. Azevedo G, Mendonça S. Risco crescente de melanoma de pele no Brasil. Rev Saude Publ 26:290-294; 1992.
7. Miller BA et al. Cancer Statistics Review 1973 - 1989. NIH Publ No 92 - 2789. Bethesda, Md: NCI 1992.
8. Greene MH. The genetics of hereditary melanoma and nevi. 1998 Update. 1999 Cancer 86:1644-57.
9. Demenais F, Chompret A, Guilloud-Bataille M, Feingold N, Grange F, Avril MF. Interactions between genetic and epidemiological risk factors in cutaneous malignant melanoma in France. Am J Hum Genet 1996; 59: A28.
10. Berwick M, Halpern A. Melanoma epidemiology. Curr Opin Oncol 1997; 9: 178-182.
11. Whiteman DC, Whiteman CA, Green AC. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 2001; 12: 69-82.
12. Armstrong BK, Kricker A. How much melanoma is caused by sun exposure? Melanoma Res 1993; 3: 395-401.
13. Bakos L, Wagner M, Bakos RM et al. Sunburn, sunscreens, and phenotypes: some risk factors for cutaneous melanoma in southern Brazil. Int J Dermatol 2002 Sep;41(9):557-62.
14. Bishop DT, Demenais F, Goldstein AM et al. Geographical variation in the penetrance of CDKN2A mutations from melanoma. J Natl Cancer Inst 2002; 94(12): 872-3.
15. Grange F, Chompret A, Guilloud-Bataille M et al. Comparison between familial and non-familial melanoma in France. Arch Dermatol 1995; 131:1154-1159.
16. Lindor NM, Greene MH et al. The concise handbook of family cancer syndromes. J Natl Cancer Inst 1998; 90:1039-1071.
17. Karakayali G, Güngör E, Lenk N et al. Neurofibromatosis and cutaneous melanoma: coincidence or association?. J Eur Acad Dermatol Venereol 1999; 12(2): 190-2.
18. Neuhausen S, Godwin AK, Gershoni-Baruch R et al. Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. Am J Hum Genet 1998; 62: 1381-1388.
19. Wooster R et al. Localization of a breast cancer susceptibility gene, BRCA 2 to chromosome 13q12-13. Science 1994; 265: 2088-2090.
20. Andersen LB, Fountain JW, Gutmann DH et al. Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines. Nat Genet 1993; 3(2): 118-121.
21. Kefford R, Bishop JN, Tucker M et al. Genetic testing for melanoma. Lancet Oncol 2002 Nov;3(11):653-4.